Drug Therapy, Combination
"Drug Therapy, Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapy with two or more separate preparations given for a combined effect.
Descriptor ID |
D004359
|
MeSH Number(s) |
E02.319.310
|
Concept/Terms |
Drug Therapy, Combination- Drug Therapy, Combination
- Combination Chemotherapy
- Drug Polytherapy
- Drug Polytherapies
- Polytherapies, Drug
- Polytherapy, Drug
- Therapy, Combination Drug
- Chemotherapy, Combination
- Chemotherapies, Combination
- Combination Chemotherapies
- Combination Drug Therapy
- Combination Drug Therapies
- Drug Therapies, Combination
- Therapies, Combination Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug Therapy, Combination".
Below are MeSH descriptors whose meaning is more specific than "Drug Therapy, Combination".
This graph shows the total number of publications written about "Drug Therapy, Combination" by people in this website by year, and whether "Drug Therapy, Combination" was a major or minor topic of these publications.
View timeline visualization
Year | Major Topic | Minor Topic | Total |
---|
1995 | 3 | 39 | 42 |
1996 | 3 | 48 | 51 |
1997 | 1 | 53 | 54 |
1998 | 2 | 64 | 66 |
1999 | 1 | 89 | 90 |
2000 | 2 | 81 | 83 |
2001 | 1 | 68 | 69 |
2002 | 1 | 122 | 123 |
2003 | 2 | 128 | 130 |
2004 | 2 | 131 | 133 |
2005 | 2 | 135 | 137 |
2006 | 1 | 126 | 127 |
2007 | 1 | 150 | 151 |
2008 | 3 | 136 | 139 |
2009 | 2 | 150 | 152 |
2010 | 4 | 171 | 175 |
2011 | 2 | 137 | 139 |
2012 | 4 | 141 | 145 |
2013 | 3 | 168 | 171 |
2014 | 4 | 152 | 156 |
2015 | 2 | 178 | 180 |
2016 | 4 | 147 | 151 |
2017 | 8 | 138 | 146 |
2018 | 10 | 141 | 151 |
2019 | 5 | 152 | 157 |
2020 | 7 | 120 | 127 |
2021 | 3 | 99 | 102 |
2022 | 0 | 31 | 31 |
2023 | 1 | 30 | 31 |
2024 | 11 | 42 | 53 |
2025 | 4 | 4 | 8 |
Below are the most recent publications written about "Drug Therapy, Combination" by people in Profiles.
-
Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH. Blood. 2025 Feb 20; 145(8):811-822.
-
Trial protocol of an open-label pilot study of oral naltrexone-bupropion combination pharmacotherapy for the treatment of methamphetamine use disorder (the NABU trial). BMJ Open. 2025 Feb 07; 15(2):e092032.
-
Lower Mortality Risk Associated With Remdesivir + Dexamethasone Versus Dexamethasone Alone for the Treatment of Patients Hospitalized for COVID-19. Clin Infect Dis. 2025 Feb 05; 80(1):63-71.
-
Selection and prioritization of candidate combination regimens for the treatment of tuberculosis. Sci Transl Med. 2025 Feb 05; 17(784):eadi4000.
-
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis. N Engl J Med. 2025 Jan 30; 392(5):468-482.
-
Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study. RMD Open. 2025 Jan 30; 11(1).
-
Combination SGLT2 Inhibitor and Glucagon Receptor Antagonist Therapy in Type 1 Diabetes: A Randomized Clinical Trial. Diabetes Care. 2025 Jan 01; 48(1):52-60.
-
Diuretic Potentiation Strategies in Acute Heart Failure. JACC Heart Fail. 2025 Jan; 13(1):14-27.
-
AGA Living Clinical Practice Guideline on Pharmacological Management of Moderate-to-Severe Ulcerative Colitis. Gastroenterology. 2024 Dec; 167(7):1307-1343.
-
Early combination therapy with SGLT2i and GLP-1 RA or dual GIP/GLP-1 RA in type 2 diabetes. Diabetes Obes Metab. 2025 Feb; 27(2):468-481.